Nidufexor
Подписчиков: 0, рейтинг: 0
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C27H22ClN3O4 |
| Molar mass | 487.94 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Nidufexor (LMB-763) is a drug which acts as a partial agonist of the farnesoid X receptor (FXR). It has reached Phase II clinical trials for the treatment of diabetic nephropathy and nonalcoholic steatohepatitis.
See also
| FXR |
|
|---|---|
| LXR | |
| |